Literature DB >> 16399621

Estrogen stimulates transcription of human immunodeficiency virus type 1 (HIV-1).

Daichi Katagiri1, Hidetoshi Hayashi, Ann Florence B Victoriano, Takashi Okamoto, Kikuo Onozaki.   

Abstract

Gene expression from human immunodeficiency virus (HIV) provirus is a crucial step for the viral replication. Here we examined a potential role of 17beta-estradiol (E2) in HIV-1 transcription. Transient luciferase expression studies revealed that E2 activated HIV-LTR reporter gene in HEK293 cells when the cells were co-transfected with estrogen receptor alpha (ERalpha) but not ERbeta expression plasmid. This E2 effect was abrogated by a specific antagonist to ER, ICI 182,780, indicating that it was mediated by ERalpha. Mutation analysis revealed that Sp1 binding site but not nuclear factor-kappa B (NF-kappaB) binding site of HIV-1 LTR is critical to the E2 effect. In addition, whereas E2 could not induce DNA-binding activity of NF-kappaB, E2 could augment both Sp1 DNA-binding and transcriptional activity. These findings suggest a contribution of estrogen for HIV-1 replication through ERalpha by augmenting Sp1 DNA-binding and transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16399621     DOI: 10.1016/j.intimp.2005.07.017

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  15 in total

Review 1.  Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.

Authors:  Rowena E Johnston; Mary M Heitzeg
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

Review 2.  The Importance of Human Immunodeficiency Virus Research for Transgender and Gender-Nonbinary Individuals.

Authors:  Sara Gianella; J Sonya Haw; Jill Blumenthal; Brooke Sullivan; Davey Smith
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

3.  Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases.

Authors:  Sabra L Klein
Journal:  Bioessays       Date:  2012-09-26       Impact factor: 4.345

4.  Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative.

Authors:  Elizabeth M Stringer; Mark Giganti; Rosalind J Carter; Wafaa El-Sadr; Elaine J Abrams; Jeffrey Sa Stringer
Journal:  AIDS       Date:  2009-11       Impact factor: 4.177

5.  Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia.

Authors:  Paula M Heron; Jadwiga Turchan-Cholewo; Annadora J Bruce-Keller; Melinda E Wilson
Journal:  AIDS Res Hum Retroviruses       Date:  2009-11       Impact factor: 2.205

Review 6.  Hormonal contraception and HIV disease progression.

Authors:  Elizabeth Stringer; Erik Antonsen
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

Review 7.  Immunogenetics of small ruminant lentiviral infections.

Authors:  Nancy Stonos; Sarah K Wootton; Niel Karrow
Journal:  Viruses       Date:  2014-08-22       Impact factor: 5.048

8.  The X awakens: multifactorial ramifications of sex-specific differences in HIV-1 infection.

Authors:  Sven Hagen; Marcus Altfeld
Journal:  J Virus Erad       Date:  2016-04-01

Review 9.  Barriers to a cure for HIV in women.

Authors:  Sara Gianella; Athe Tsibris; Liz Barr; Catherine Godfrey
Journal:  J Int AIDS Soc       Date:  2016-02-18       Impact factor: 5.396

10.  Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection.

Authors:  Marta Rodriguez-Garcia; Nabanita Biswas; Mickey V Patel; Fiona D Barr; Sarah G Crist; Christina Ochsenbauer; John V Fahey; Charles R Wira
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.